Hematogen FA Capsules

Dosage Form: capsule
Hematogen FA

Liquid - Iron in a Soft Gelcap

DESCRIPTION

CONTENTS : Each maroon and brown soft gelatin capsule contains:

Ferrous fumarate USP........................................................................200 mg
(66 mg elemental iron)

Ascorbic acid USP..............................................................................250 mg

Folic acid USP........................................................................................1 mg

Cyanocobalamin USP.........................................................................10 mcg

DISCUSSION : The amount of elemental iron and the absorption of the iron components of commercial iron preparations vary widely. It is further established that certain "accessory components" may be included to enhance absorption and utilization of iron. Hematogen FA Capsules are formulated to provide the essential factors for a complete, versatile hematinic.

ACTIONS

HIGH ELEMENTAL IRON CONTENT: Ferrous fumarate, used in Hematogen FA Capsules, is an organic iron 1,2 complex which has the highest elemental iron content of any hematinic salt - 33% This compares with 20% for ferrous sulfate (heptahydrate) and 13% for ferrous gluconate.

MORE COMPLETE ABSORPTION: It has been repeatedly shown that Ascorbic acid, when given in sufficient amounts, can increase the absorption of ferrous Iron from the gastrointestinal tract. The absorption promoting effect is mainly due to the reducing action of ascorbic acid within the gastrointestinal lumen, which helps to prevent or delay the formation of insoluble or less dissociated ferric compounds. Iron absorption has been shown to increase sharply with increasing amounts of ascorbic acid, showing a gain in absorption of approximately 40% at 250 mg. Above 250 mg, the gain becomes insignificant, with an additional gain of only approximately 8% at 500 mg. Each Hematogen FA capsule contains 250 mg of ascorbic acid, believed to be the optimal amount

PROMOTES MOVEMENT OF PLASMA IRON: Ascorbic acid also plays an important role in the movement of plasma iron to storage depots in the tissues .The action, which leads to the transport of plasma iron to ferritin, presumably involves its reducing effect, converting transferrin iron from the ferric to the ferrous state. There is also evidence that ascorbic acid improves iron utilization, presumably as a further result of its reducing action and some evidence that effect upon erythropoiesis. Ascorbic acid is further alleged to enhance the conversion of folic acid to a more physiologically active form, folinic acid, which would make it even more important in the treatment of anemia since it would aid in the utilization of dietary folic acid."

EXCELLENT ORAL TOLERATION: Ferrous fumarate is used in Hematogen FA Capsules because it is less likely to cause the gastric disturbances so often associated with oral iron therapy. Ferrous fumarate has a low ionization constant and high solubility in the entire pH range of the gastrointestinal tract. It does not precipitate proteins or have the astringency of more ionizable forms of iron, and does not interfere with proteolytic or diastatic activities of the digestive system. Because of excellent oral toleration, Hematogen FA Capsules can usually be administered between meals when iron absorption is maximal.

FOLIC ACID SUPPLEMENTATION: The use of supplemental folic acid may be indicated in patients with increased requirements for this vitamin, such as iron deficiency anemia. Folic acid administration may 12 reduce the risk of neural tube defects in the developing fetus . Folic acid has also been shown to reduce circulating homocysteine leveIs in the blood . FoIate as 5-methyltetrahydrofolate and B as  methylcobalamin are involved in the remethylation reaction of homocysteine to methionine. Elevated homocysteine plasma levels are associated with increased risk of preeclampsia, neural tube defects, myocardial infarction and artherosclerosis.

TOXICITY: Ferrous fumarate was found to be the least toxic of three popular oral iron salts, with an oral LD of 630 mg/kg. In the same report, the LD of ferrous gluconate was reported to be 320 mg/kg and ferrous sulfate 230 mg/kg.

INDICATIONS

For the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. it may have a direct only

CONTRAINDICATIONS

Hemochromatosis and hemosiderosis are contraindications to iron therapy. Folic acid is contraindicated in patients with pernicious anemia (see PRECAUTIONS).

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. PRECAUTIONS

Folic acid should not be prescribed until the diagnosis of pernicious anemia has been eliminated, since it can 14 alleviate the hematologic manifestations, while allowing neurological damage to continue undetected.

ADVERSE REACTIONS

Average capsule doses in sensitive individuals or excessive dosage may cause nausea, skin rash, vomiting, diarrhea, precordial pain, or flushing of the face and extremities.

DOSAGE AND ADMINISTRATION

Usual adult dose is 1 soft gelatin capsule daily.

HOW SUPPLIED

Capsules NDC 63044-632-17, Unit Dose Box 100

CAUTION: Federal law prohibits dispensing without prescription.

Distributed by:                                                 Manufactured by
Nnodum Pharmaceuticals                                Banner Pharmacaps
Cincinnati, Ohio 45229                                    Olds, Canada

BIBLIOGRAPHY

'Berk, M.S. and Novich, M.A.: 'Treatment of Iron Deficiency Anemia With Ferrous Fumarate," Am. J. Obst. & Gynec., 203-206, 1962. 'Shapleigh, J.B., and Monigomery, A.:Am. Pract. & Dig. Treat. 1 Q-461 , 1959. 3 Brise, H. and Hallberg, L.: "Effect of Ascorbic Acid on Iron Absorption," Acta. Med Scand.171:376,51-58,1962. 4 ‘New Drugs, p. 309, AMA, Chicago, 1966. 5 'Mazur, A., Green, S. and Carleton, A,: "Mechanism of Plasma Iron Incorporation into Hepatic Ferritin," J. Bio. Chern. 3:595-603, 1960. 'Greenberg, S.M, Tucker, A. E., Mathues, Hand JD: "Iron Absorption and Metabolism, I. Interrelationship of Ascorbic Acid and Vitamin E," J. Nutrition 6319:31,}957 'Moore, C.V and Dubach, R "Observatiol).S"9!)tl§~rJ1~P?f Iron fromFoodsTag~edv-:ith ~ron frans. A~. f'hysic.64:~1.~, ~ ~uDac1i, R. and-MoOte, C V Studies in Iron Transportation and Metabolism, "Arch. Int. Med 95:181,1955. 'Gorten, M K. and Bradley, J E.: "The Treatment of Nutritional Anemia in Infancy and Childhood with Oral Iron and Ascorbic Acid," J Pediatrics, 45:1, 1954. ,oMazur, A.: "Role of Ascorbic Acid in the Incorporation of Plasma Iron into Ferritin," Ann. N.Y. Acad. Sci, 92:223-229, .1961. I'COX, E.V. et al.: 'The Anemia of Scurvy," Amer. J. Med 42:220-227,1967. "McEvoy, G.K., Ed.: AHFS Drug Information, p. 2667-2669, Am. Soc. Hosp. Pharm., Bethesda, 1996. '3Berenbaum, M.C. et al.: Blood, 15:540, 1960. "Dru~ Information for the Health Care Professional, p.1365-1368, U S Phar- macopeial Conven., Rockville, 1995. Franken DG, Boers GH, Blom HJ, Trijbels JM "Effect of various regi- mens of vitamin B, and folic acid on mild hyperhomocystelnemia in vascular patients." J Inherit. Metab. Dis 1994; 17:159-62. "Brattstrom L, Israeisson B, Norrving B, et al. "Impaired homocysteine metabolism in early- onset cerebral and peripheral occlusive disease - effects 01 pyridoxine and folic acid treatment." Atheroscle- rosi~ 1990; 812004-6. "Ka'1!J S. Wong PWK, NoruslS-t.x:"Homocysteinemla due_to folate deficiency." Me- tabolism~9$1!"4S8-62. ,~ BH.SI8w..-SO';Savage DG, Lindernbaum J. "Dia9nosis of cobalamin deficiency. "IL usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J. Hema- 1011990; 34 90-98. '"Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs, C, van Geijn HP 1985 "Underj:ging disorder associated with severe early-onset preeclampsia." Am. J. Obstet. Gy- necol. 173: 1042-1046. Mills JL, McPartlin JM, Kirke PN, Lee Y J, Conley MR, Weir DG, Scott JM 1995. "Ho-mocysteine metabolism in pregnancies complicated by neural-tube defects." Lancet. 345: 149-151. " Steegers- Theunissen RP, Boers GH, Blom HJ, Nijhuis JG, Thomas CM, Borm GF, Eskes TK. 1995. "Neural tube defects and elevated homocysteine levels in amniotic fluid." Am. J. Obstel Gynecol172 1436-1441. "Landgren F. Is- raelsson B, Lindgren A, Hultberg B, Andersson A, Brattstrom L 1995. "Plasma homocysteine in acute my- ocardial infarction: Homocysteine-lowering effect of folic acid." J. Intern. Med. 237: 381-388. '3Mayer EL, Ja- cobsen DW, Robinson K. 1996. "Homocysteine and Coronary Atherosclerosis." J.Am. Coli. Cardiol27: 517-27.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
HEMATOGEN FA 
hematogen fa  capsule Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 63044-632 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength FERROUS FUMARATE (IRON) FERROUS FUMARATE 200 mg ASCORBIC ACID (ASCORBIC ACID) ASCORBIC ACID 250 mg FOLIC ACID (FOLIC ACID) FOLIC ACID 1 mg CYANOCOBALAMIN (CYANOCOBALAMIN) CYANOCOBALAMIN 10 ug Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color BROWN (maroon and brown) Score no score Shape CAPSULE Size 1mm Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 63044-632-17 10 BLISTER PACK In 1 BOX contains a BLISTER PACK 1 10 CAPSULE In 1 BLISTER PACK This package is contained within the BOX (63044-632-17)
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/2005
Labeler - Nnodum Pharmaceuticals (960457273) Establishment Name Address ID/FEI Operations BANNER PHARMACAPS 242721744 MANUFACTURE Revised: 12/2009Nnodum Pharmaceuticals More Hematogen FA Capsules resources Hematogen FA Capsules Use in Pregnancy & Breastfeeding Drug Images Hematogen FA Capsules Drug Interactions Hematogen FA Capsules Support Group 11 Reviews for Hematogen FA - Add your own review/rating Compare Hematogen FA Capsules with other medications Anemia Vitamin/Mineral Supplementation and Deficiency

Read More:

Group IV antiarrhythmics

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

See also

Medical conditions associated with group IV antiarrhythmics:

Angina Angina Pectoris Prophylaxis Arrhythmia Atrial Fibrillation Atrial Flutter Bipolar Disorder Cluster Headaches Heart Failure High Blood Pressure Idiopathic Hypertrophic Subaortic Stenosis Migraine Prevention Nocturnal Leg Cramps Raynaud's Syndrome Supraventricular Tachycardia Drug List: Diltia-Xt-24-Hour-Sustained-Release-Capsules Diltiazem-Hydrochloride-Sr Cartia-Xt-24-Hour-Sustained-Release-Beads-Capsules Calan-Sr-Controlled-Release-Tablets Cardizem Isoptin-Sr-Controlled-Release-Tablets Tiazac Verelan-Pm-Sustained-Release-Capsules-Controlled-Onset Diltiazem-Hydrochloride-Cd Calan Cardizem-La-24-Hour-Extended-Release-Beads-Tablets Isoptin Cardizem-Cd-24-Hour-Sustained-Release-Beads-Capsules Verelan-Sustained-Release-Pellet-Filled-Capsules Taztia-Xt-24-Hour-Extended-Release-Beads-Capsules Covera-Hs-Sustained-Release-Tablets-Controlled-Onset Dilacor-Xr-24-Hour-Sustained-Release-Capsules Dilt-Xr-24-Hour-Sustained-Release-Capsules Diltiazem-Hydrochloride-Xr Diltiazem-Hydrochloride-Xt Diltzac Matzim-La

Read More:

Atrial Fibrillation Medications

Definition of Atrial Fibrillation:

A condition where there is disorganised electrical conduction in the atria, resulting in ineffective pumping of blood into the ventricle.

Acronym: AF

Drugs associated with Atrial Fibrillation

The following drugs and medications are in some way related to, or used in the treatment of Atrial Fibrillation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Atrial FibrillationPrevention of Thromboembolism in Atrial Fibrillation (24 drugs) Learn more about Atrial Fibrillation

Medical Encyclopedia:

Atrial fibrillation/flutter

Harvard Health Guide:

Symptoms and treatment for Atrial Fibrillation
Drug List:Betapace-AfBreviblocCardizemCardizem-Cd-24-Hour-Sustained-Release-Beads-CapsulesCardizem-La-24-Hour-Extended-Release-Beads-TabletsCartia-Xt-24-Hour-Sustained-Release-Beads-CapsulesCatapresCoregCoreg-Cr-Extended-Release-CapsulesCorvertDigitekDilacor-Xr-24-Hour-Sustained-Release-CapsulesDilt-Xr-24-Hour-Sustained-Release-CapsulesDiltia-Xt-24-Hour-Sustained-Release-CapsulesDiltiazem-Hydrochloride-CdDiltiazem-Hydrochloride-SrDiltiazem-Hydrochloride-XrDiltiazem-Hydrochloride-XtDiltzacLanoxicapsLanoxinLopressorMatzim-LaMetoprolol-Succinate-ErMultaqRythmolRythmol-Sr-Sustained-Release-CapsulesSotalol-Hydrochloride-AfTambocorTiazacToprolXarelto

Read More:

Vulvodynia Medications

Definition of Vulvodynia: Vulvodynia is described as chronic vulvar discomfort with complaints of burning and superficial irritation.

Drugs associated with Vulvodynia

The following drugs and medications are in some way related to, or used in the treatment of Vulvodynia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List: Aventyl Carbatrol-Sustained-Release-Capsules Effexor-Xr-Extended-Release-Capsules Elavil Epitol Fanatrex Gabarone Lexapro Neurontin Norpramin Pamelor Prozac Prozac-Weekly-Delayed-Release-Capsules Rapiflux Tegretol Tegretol-Xr-Sustained-Release-Tablets Topamax Topamax-Sprinkle Topiragen Vanatrip

Read More:

Fibromyalgia Medications

Drugs associated with Fibromyalgia

The following drugs and medications are in some way related to, or used in the treatment of Fibromyalgia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Fibromyalgia Epicondylitis, Tennis Elbow (17 drugs) Learn more about Fibromyalgia

Medical Encyclopedia:

Fibromyalgia

Harvard Health Guide:

Symptoms and treatment for Fibromyalgia

Drugs.com Health Center:

Fibromyalgia
Drug List: 5-Htp Amibid-La Amrix-Extended-Release-Capsules Comfort-Pac-With-Cyclobenzaprine Cymbalta Deltasone Desyrel Desyrel-Dividose Effexor Effexor-Xr-Extended-Release-Capsules Elavil Fanatrex Fexmid Flexeril Gabarone Ganidin-Nr Gg-200-Nr Guaifenesin-La Guaifenex-G Guaifenex-La Lexapro Lyrica Meticorten Mobic Mucinex Muco-Fen-1200 Neurontin Nuvigil Organidin-Nr-Immediate-Release-Capsules Pristiq Prozac Prozac-Weekly-Delayed-Release-Capsules Q-Bid-La Rapiflux Revia Savella Skelaxin Sterapred Sterapred-Ds Strattera Topamax Topamax-Sprinkle Topiragen Vanatrip Xyrem

Read More:

Calcium channel blocking agents

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Calcium channel blockers block voltage gated calcium channels and inhibits the influx of calcium ions into cardiac and smooth muscle cells. The decrease in intracellular calcium reduces the strength of heart muscle contraction, reduces conduction of impulses in the heart, and causes vasodilatation.

Decrease in intracellular calcium in the heart decreases cardiac contractility. Decreased calcium in the vascular smooth muscle reduces its contraction and therefore causes vasodilatation.

Decrease in cardiac contractility decreases cardiac output and vasodilatation decreases total peripheral resistance, both of which cause a drop in blood pressure.

Calcium channel blocking agents are used to treat hypertension.

See also

Medical conditions associated with calcium channel blocking agents:

Angina Angina Pectoris Prophylaxis Arrhythmia Atrial Fibrillation Atrial Flutter Bipolar Disorder Cluster Headaches Coronary Artery Disease Heart Failure High Blood Pressure Hypertensive Emergency Hypertrophic Cardiomyopathy Idiopathic Hypertrophic Subaortic Stenosis Ischemic Stroke Migraine Prevention Nocturnal Leg Cramps Premature Labor Raynaud's Syndrome Subarachnoid Hemorrhage Supraventricular Tachycardia Drug List: Afeditab-Cr Diltia-Xt-24-Hour-Sustained-Release-Capsules Diltiazem-Hydrochloride-Sr Nimotop Adalat Cartia-Xt-24-Hour-Sustained-Release-Beads-Capsules Calan-Sr-Controlled-Release-Tablets Cardizem Isoptin-Sr-Controlled-Release-Tablets Nifediac-Cc Tiazac Verelan-Pm-Sustained-Release-Capsules-Controlled-Onset Diltiazem-Hydrochloride-Cd Procardia Adalat-Cc-Sustained-Release-Tablets Calan Cardizem-La-24-Hour-Extended-Release-Beads-Tablets Procardia-Xl-Sustained-Release-Tablets Isoptin Nifedical-Xl Cardizem-Cd-24-Hour-Sustained-Release-Beads-Capsules Norvasc Plendil Dynacirc-Cr-Extended-Release-Tablets Verelan-Sustained-Release-Pellet-Filled-Capsules Taztia-Xt-24-Hour-Extended-Release-Beads-Capsules Cardene Cardene-Iv Cardene-Sr-Sustained-Release-Capsules Cleviprex Covera-Hs-Sustained-Release-Tablets-Controlled-Onset Dilacor-Xr-24-Hour-Sustained-Release-Capsules Dilt-Xr-24-Hour-Sustained-Release-Capsules Diltiazem-Hydrochloride-Xr Diltiazem-Hydrochloride-Xt Diltzac Dynacirc Matzim-La Sular-Extended-Release-Tablets Vascor

Read More:

Migraine Prevention (Migraine Prophylaxis) Medications

Drugs associated with Migraine Prevention

The following drugs and medications are in some way related to, or used in the treatment of Migraine Prevention. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List: Aventyl Benicar Blocadren Botox Calan Calan-Sr-Controlled-Release-Tablets Catapres Catapres-Tts-Patches Corgard Covera-Hs-Sustained-Release-Tablets-Controlled-Onset Depakote Depakote-Er-Extended-Release-Tablets Depakote-Sprinkles Elavil Inderal Inderal-La-Sustained-Release-Capsules Innopran-Xl-Sustained-Release-Bead-Capsules Isoptin Isoptin-Sr-Controlled-Release-Tablets Kemstro Klonopin Klonopin-Wafer-Orally-Disintegrating-Tablets Lioresal Nardil Nimotop Norvasc Pamelor Prinivil Stavzor Tenormin Topamax Topamax-Sprinkle Topiragen Vanatrip Verelan-Sustained-Release-Pellet-Filled-Capsules Verelan-Pm-Sustained-Release-Capsules-Controlled-Onset Vitamin-B2 Zestril Zonegran

Read More:

Hydrocephalus Medications

Definition of Hydrocephalus: Hydrocephalus is an accumulation of cerebrospinal fluid in the ventricles of the brain, leading to their enlargement and swelling.

Drugs associated with Hydrocephalus

The following drugs and medications are in some way related to, or used in the treatment of Hydrocephalus. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Hydrocephalus

Micromedex Care Notes:

Hydrocephalus Hydrocephalus In Children

Medical Encyclopedia:

Hydrocephalus

Harvard Health Guide:

Symptoms and treatment for Hydrocephalus
Drug List: Diamox Diamox-Sequels-Sustained-Release-Capsules

Read More:

Proton pump inhibitors

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Proton pump inhibitors act by irreversible inhibition of the H+/K+ ATPase, in the parietal cells of the stomach. It markedly inhibits gastric acid secretion and has a long duration of action. They are used for treatment of gastric and duodenal ulcers, gastroesophageal reflux disease and other excessive gastrointestinal acid secretory disorders.

See also

Medical conditions associated with proton pump inhibitors:

Aspiration PneumoniaBarrett's EsophagusDuodenal UlcerDuodenal Ulcer ProphylaxisErosive EsophagitisGastrointestinal HemorrhageGERDHelicobacter Pylori InfectionIndigestionMultiple Endocrine AdenomasNSAID-Induced Gastric UlcerNSAID-Induced Ulcer ProphylaxisPathological Hypersecretory ConditionsPeptic UlcerStomach UlcerStress Ulcer ProphylaxisSystemic MastocytosisZollinger-Ellison Syndrome Drug List:ZegeridAciphexNexium_IvNexiumPrevacidProtonixKapidexDexilant-Delayed-Release-CapsulesPrilosecPrilosec-Otc-Delayed-Release-CapsulesPrevacid-Solutab-Orally-Disintegrating-TabletsZegerid-OtcPrevacid-I-VPrevacid-OtcProtonix-I-V

Read More:

Cevi-Bid Controlled-Release Capsules

Pronunciation: a-SKOR-bik AS-id
Generic Name: Ascorbic Acid
Brand Name: Examples include Cemill and Cevi-Bid
Cevi-Bid Controlled-Release Capsules are used for:

Treating and preventing low levels of vitamin C. It may also be used for other conditions as determined by your doctor.

Cevi-Bid Controlled-Release Capsules are a vitamin. It works by supplementing vitamin C, which is used in many functions in the body.

Do NOT use Cevi-Bid Controlled-Release Capsules if: you are allergic to any ingredient in Cevi-Bid Controlled-Release Capsules

Contact your doctor or health care provider right away if any of these apply to you.

Before using Cevi-Bid Controlled-Release Capsules:

Some medical conditions may interact with Cevi-Bid Controlled-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you have diabetes, glucose-6-phosphate dehydrogenase deficiency, a high iron level in the blood, anemia (eg, sickle cell, sideroblastic, thalassemia), or kidney stones

Some MEDICINES MAY INTERACT with Cevi-Bid Controlled-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

Anticoagulants (eg, warfarin) because side effects may be increased by Cevi-Bid Controlled-Release Capsules

This may not be a complete list of all interactions that may occur. Ask your health care provider if Cevi-Bid Controlled-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Cevi-Bid Controlled-Release Capsules:

Use Cevi-Bid Controlled-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Cevi-Bid Controlled-Release Capsules may be taken with or without food. Swallow Cevi-Bid Controlled-Release Capsules whole. Do not break, crush, or chew before swallowing. Take Cevi-Bid Controlled-Release Capsules with a full glass of water (8 oz/240 mL). Do not lie down for 30 minutes after taking Cevi-Bid Controlled-Release Capsules. If you miss a dose of Cevi-Bid Controlled-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Cevi-Bid Controlled-Release Capsules.

Important safety information: Do not take large doses of vitamins (megadoses or megavitamin therapy) while taking Cevi-Bid Controlled-Release Capsules unless directed to by your doctor. Cevi-Bid Controlled-Release Capsules may cause incorrect results with some in-home cholesterol test kits. Check with your doctor or pharmacist if you are taking Cevi-Bid Controlled-Release Capsules and need to check your cholesterol at home. Diabetes patients - Cevi-Bid Controlled-Release Capsules may cause incorrect test results with some urine glucose tests. Check with your doctor before you adjust the dose of your diabetes medicine or change your diet. Cevi-Bid Controlled-Release Capsules may cause incorrect test results with kits used to check for blood in the stool. Check with your doctor if you are taking Cevi-Bid Controlled-Release Capsules when using the test kit. PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Cevi-Bid Controlled-Release Capsules, discuss with your doctor the benefits and risks of using Cevi-Bid Controlled-Release Capsules during pregnancy. Cevi-Bid Controlled-Release Capsules are excreted in breast milk. If you are or will be breast-feeding while you are using Cevi-Bid Controlled-Release Capsules, check with your doctor or pharmacist to discuss the risks to your baby. Possible side effects of Cevi-Bid Controlled-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; nausea; upset stomach; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); kidney stones (eg, abdominal pain/back pain, painful urination).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Cevi-Bid side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include gout.

Proper storage of Cevi-Bid Controlled-Release Capsules:

Store Cevi-Bid Controlled-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Cevi-Bid Controlled-Release Capsules out of the reach of children and away from pets.

General information: If you have any questions about Cevi-Bid Controlled-Release Capsules, please talk with your doctor, pharmacist, or other health care provider. Cevi-Bid Controlled-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people. If your symptoms do not improve or if they become worse, check with your doctor. Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Cevi-Bid Controlled-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012 Database Edition 12.1.1.002 Copyright © 2012 Wolters Kluwer Health, Inc. More Cevi-Bid resources Cevi-Bid Side Effects (in more detail) Cevi-Bid Use in Pregnancy & Breastfeeding Cevi-Bid Drug Interactions Cevi-Bid Support Group 0 Reviews for Cevi-Bid - Add your own review/rating Compare Cevi-Bid with other medications Dietary Supplementation Scurvy Urinary Acidification

Read More:

Bartter Syndrome Medications

Definition of Bartter Syndrome: Bartter syndrome refers to a rare group of conditions that affect the kidneys. People with Bartter syndrome have a loss of potassium (hypokalemic alkalosis) and a rise in the hormone aldosterone.

Drugs associated with Bartter Syndrome

The following drugs and medications are in some way related to, or used in the treatment of Bartter Syndrome. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Bartter Syndrome Gitelman Syndrome (3 drugs) Learn more about Bartter Syndrome

Medical Encyclopedia:

Bartter syndrome
Drug List: Indocin Indocin-Iv Indocin-Sr-Sustained-Release-Capsules

Read More:

Methylxanthines

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Methylxanthines act as bronchodilators by relaxing bronchial smooth muscle and helps the constricted airways to dilate. The exact mechanism of action with regards to methylxanthine causing bronchodilatation is not well understood but it appears that methylxanthines inhibit the enzyme phosphodiesterase, which degrades cyclic AMP, so methylxanthines tend to increase the concentration of cyclic AMP.

Methylxanthines are bronchodilators used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

See also

Medical conditions associated with methylxanthines:

Apnea of Prematurity Asthma Asthma, acute Asthma, Maintenance Bronchitis COPD Drug List: Theo-24-Sustained-Release-Capsules Uniphyl-Sustained-Release-Tablets Theo-Dur Choledyl Choledyl-Sa Dilor Dilor-400 Dylix-Elixir Elixophyllin-Elixir Lufyllin Lufyllin-400 Neothylline Phyllocontin Quibron-T Quibron-T-Sr Theo-Time Theocap-Sustained-Release-Capsules Theochron-Sustained-Release-Tablets Theolair-Tablets Truphylline Truxophyllin

Read More:

Bartonellosis Medications

Definition of Bartonellosis: Cat scratch disease is an infectious illness caused by the bacteria More...

Drugs associated with Bartonellosis

The following drugs and medications are in some way related to, or used in the treatment of Bartonellosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Bartonellosis

Medical Encyclopedia:

Cat scratch disease
Drug List: Azithromycin-3-Day-Dose-Pack Doryx-Delayed-Release-Capsules Doxy-100 Doxy-200 E-E-S-Granules-Suspension E-E-S-200 E-E-S-400 E-E-S-400-Filmtab Ery-Tab Eryc-Delayed-Release-Particles-Capsules Eryped-Drops Erythrocin Erythromycin-Lactobionate-I-V Erythrocin-Stearate-Filmtab Ilosone Monodox Ocudox-Convenience-Kit Oraxyl Pce Rifadin Rifadin-Iv Rimactane Vibra-Tabs Vibramycin Zithromax Zmax-Extended-Release-Oral-Suspension

Read More:

Syphilis, Early Medications

Drugs associated with Syphilis, Early

The following drugs and medications are in some way related to, or used in the treatment of Syphilis, Early. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List: Ala-Tet Beepen-Vk Bicillin-L-A-Suspension Doryx-Delayed-Release-Capsules Doxy-100 Doxy-200 E-E-S-Granules-Suspension E-E-S-200 E-E-S-400 E-E-S-400-Filmtab Ery-Tab Eryc-Delayed-Release-Particles-Capsules Eryped-Drops Erythrocin Erythromycin-Lactobionate-I-V Erythrocin-Stearate-Filmtab Ilosone Permapen-Isoject Monodox Ocudox-Convenience-Kit Oraxyl Pc-Pen-Vk Pce Pen-V Penicillin-G-Procaine-Injectable-Suspension Penicillin-Vk Pfizerpen Rocephin Sumycin Veetids Vibra-Tabs Vibramycin Wycillin

Read More:

ADHD (Attention Deficit Hyperactivity Disorder) Medications

Definition of ADHD: An inability to control behaviour due to difficulty in processing neural stimuli. More...

Drugs associated with ADHD

The following drugs and medications are in some way related to, or used in the treatment of ADHD. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under ADHD Oppositional Defiant Disorder (1 drug) Learn more about ADHD (Attention Deficit Hyperactivity Disorder)

Medical Encyclopedia:

Attention deficit hyperactivity disorder (ADHD)

Drugs.com Health Center:

Mental Health Disorders
Drug List: 5-Htp Adderall Adderall-Xr-Extended-Release-Capsules Aminomine Animi-3 Animi-3-With-Vitamin-D Concerta Cylert Daytrana Desoxyn Desoxyn-Gradumet Dexedrine Dextrostat Divista Eldepryl Epa-Fish-Oil Fish_Oil Fish-Oil-Ultra Focalin Focalin-Xr-Extended-Release-Capsules Icar-Prenatal-Essential-Omega-3 Intuniv Kapvay Liquadd-Solution Lovaza Marine-Lipid-Concentrate Maxepa Maxitears-Dry-Eye-Formula Maxivision-Omega-3-Formula Metadate-Cd-Controlled-Release-Capsules Metadate-Er Methylin Methylin-Er-Controlled-Release-Tablets Mi-Omega Mi-Omega-Nf Norpramin Omacor Omega-500 Pristiq Procentra-Solution Proepa Ritalin Ritalin-La-Extended-Release-Capsules Ritalin-Sr-Controlled-Release-Tablets Sea-Omega Sea-Omega-30 Sea-Omega-70 Strattera Theratears-Nutrition Theromega Tofranil Tofranil-Pm Vyvanse Zelapar

Read More:

Nabilone 1mg Capsules

Nabilone 1 mg Capsules

(nabilone)

Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If you experience any side effect and this becomes serious, tell your doctor or pharmacist. In this leaflet: 1. What Nabilone is and what it is used for 2. Before you take Nabilone Capsules 3. How to take Nabilone Capsules 4. Possible side effects 5. How to store Nabilone Capsules 6. Further information What Nabilone Is And What It Is Used For

Nabilone is a medicine that helps to reduce nausea and vomiting caused by many anticancer medicines.

Nabilone is often used when other medicines have not helped your nausea or vomiting.

Nabilone is a man-made chemical known as a cannabinoid. It is not made from the Cannabis plant but it is similar to some marijuana extracts and can cause similar effects.

Before You Take Nabilone Capsules Do not take Nabilone If you are allergic (hypersensitive) to any of the other ingredients of Nabilone Capsules (these are listed in section 6, "Further Information"). If your nausea / vomiting is not due to anticancer treatment. If you are under 18 years. Nabilone is not meant for children. Take special care with Nabilone

It is best if you take Nabilone Capsules in hospital, as you may experience side effects.

Tell your doctor before you start treatment if you have any of the following problems or if you develop any of these during treatment:

Any liver problems. High blood pressure or any other heart problem. Any mental illness, for example depression or schizophrenia. Taking other medicines

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

In particular, tell your doctor if you are taking any sleeping pills, pain killers or tranquillisers.

Taking Nabilone with alcohol

Do not drink alcohol while you are taking Nabilone.

Pregnancy and breast-feeding

Tell your doctor before you start treatment

If you are pregnant, if you think that you are pregnant, or if you intend to become pregnant. If you are breast-feeding or planning to breast-feed.

Your doctor will then decide if you can take this medicine.

Driving and using machines

Nabilone Capsules may cause side effects such as sleepiness, confusion, hallucinations, a feeling of dizziness or spinning, poor muscle co-ordination, problems with your sight and problems with concentration. These side effects may occur up to 3 days after taking Nabilone. This may affect your ability to drive and operate machinery. Do not drive or operate machinery if you experience any of these side effects.

How To Take Nabilone Capsules

Always take Nabilone exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure how to take it. Your doctor will usually start you on the lowest possible dose.

It is best if you take Nabilone Capsules in hospital, especially the first time that you take Nabilone. This is because you may experience side effects.

The hospital doctor or nurse may give you your first dose the night before you start chemotherapy and the second dose one to three hours before it begins.

Swallow the capsules with water.

Dose The usual dose is 1 or 2 capsules twice a day. You should never take more than 2 capsules three times a day. You can take Nabilone while you are having chemotherapy treatment and for up to 2 days after your last dose of chemotherapy.

The dosing recommendations for elderly patients are the same as for other adults.

If you take more Nabilone than you should

If you ever take too many capsules, tell your doctor or get someone to take you to the nearest hospital casualty department immediately together with your medicine to show to the doctor.

If you forget to take Nabilone

If you miss a dose, wait until it is time for the next dose, and then continue as before.

Do not take a double dose to make up for a forgotten dose.

Possible Side Effects

Like all medicines, Nabilone can cause side effects, although not everybody gets them.

Side effects that you may experience are: Feeling sleepy, relaxed, or "high". A few patients have had hallucinations, felt confused, depressed, anxious or had other changes in their mood or mental state. A feeling of dizziness or spinning, especially when you stand up. Poor muscle co-ordination. Dry mouth, problems with your sight or concentration, difficulty sleeping, or headaches. Shaking, a faster heart beat than normal, low blood pressure, losing your appetite and stomach pains.

Any changes in your mood, such as feeling depressed, relaxed or "high", may last for 2 or 3 days after you stop taking Nabilone. You may find that you get used to these feelings.

If you have any of these side effects, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

How To Store Nabilone Capsules Keep Nabilone Capsules out of the reach and sight of children. Do not use Nabilone after the expiry date which is stated on the bottle and carton after "EXP". The expiry date refers to the last day of that month. Keep the container tightly closed. Store your capsules at room temperature (15-25°C) in a dry place. If your doctor tells you to stop taking the capsules, please take them back to the pharmacist. Medicines should not be disposed of via wastewater or household waste. Only keep the capsules if your doctor tells you to. Further Information What Nabilone contains

Active substance: Nabilone. Each capsule contains 1 mg of nabilone.
Other ingredients: Povidone, starch, gelatin and the colourants E132, E172 and E171.

What Nabilone looks like and contents of the pack Nabilone capsules are blue and white and have CL 3101 printed on them. Each bottle or blister pack of Nabilone contains 20 capsules. Marketing Authorisation Holder Meda Pharmaceuticals Ltd. Skyway House Parsonage Road Takeley Bishop's Stortford CM22 6PU UK Manufacturer Dales Pharmaceuticals Limited Snaygill Industrial Estate Keighley Road Skipton North Yorkshire BD23 2RW UK

For any information about this medicine, please contact the Marketing Authorisation Holder.

This leaflet was last approved in July 2009.

F687

Read More:

Anesthetic Adjunct Medications

Definition of Anesthetic Adjunct: Anesthetic adjuncts are used to augment specific components of anesthesia, permitting lower doses of general anesthetics with fewer side effects.

Drugs associated with Anesthetic Adjunct

The following drugs and medications are in some way related to, or used in the treatment of Anesthetic Adjunct. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List: Brevital-Sodium Dilaudid-Hp Palladone-Extended-Release-Capsules Pentothal Stadol-Solution Sublimaze

Read More:

Carbetapentane/Guaifenesin Sustained-Release Capsules

Pronunciation: car-bay-ta-PEN-tane/gwye-FEN-eh-sin
Generic Name: Carbetapentane/Guaifenesin
Brand Name: Dynex VR
Carbetapentane/Guaifenesin Sustained-Release Capsules are used for:

Relieving unproductive cough and reducing mucus in the chest due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.

Carbetapentane/Guaifenesin Sustained-Release Capsules are a cough suppressant and expectorant combination. The cough suppressant works in the brain to help decrease the cough reflex. The expectorant works by thinning mucus (phlegm) in the lungs, making it less sticky and easier to cough up. This makes coughs more productive.

Do NOT use Carbetapentane/Guaifenesin Sustained-Release Capsules if: you are allergic to any ingredient in Carbetapentane/Guaifenesin Sustained-Release Capsules

Contact your doctor or health care provider right away if any of these apply to you.

Before using Carbetapentane/Guaifenesin Sustained-Release Capsules:

Some medical conditions may interact with Carbetapentane/Guaifenesin Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you have chronic cough due to smoking, asthma, chronic bronchitis, or emphysema, or if your cough produces large amounts of mucus if you have a history of heart problems, high blood pressure, prostate problems, an overactive thyroid, diabetes, or glaucoma

Some MEDICINES MAY INTERACT with Carbetapentane/Guaifenesin Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines. However, no specific interactions with Carbetapentane/Guaifenesin Sustained-Release Capsules are known at this time.

This may not be a complete list of all interactions that may occur. Ask your health care provider if Carbetapentane/Guaifenesin Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Carbetapentane/Guaifenesin Sustained-Release Capsules:

Use Carbetapentane/Guaifenesin Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Carbetapentane/Guaifenesin Sustained-Release Capsules may be taken with or without food. Drinking extra fluids while you are taking Carbetapentane/Guaifenesin Sustained-Release Capsules are recommended. Check with your doctor for instructions. Swallow Carbetapentane/Guaifenesin Sustained-Release Capsules whole. Do not break, crush, or chew before swallowing. If you miss a dose of Carbetapentane/Guaifenesin Sustained-Release Capsules and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Carbetapentane/Guaifenesin Sustained-Release Capsules.

Important safety information: Carbetapentane/Guaifenesin Sustained-Release Capsules may cause drowsiness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Carbetapentane/Guaifenesin Sustained-Release Capsules. Using Carbetapentane/Guaifenesin Sustained-Release Capsules alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks. Avoid drinking alcohol or taking other medications that cause drowsiness (eg, sedatives, tranquilizers) while taking Carbetapentane/Guaifenesin Sustained-Release Capsules. Carbetapentane/Guaifenesin Sustained-Release Capsules will add to the effects of alcohol and other depressants. Ask your pharmacist if you have questions about which medicines are depressants. If cough persists for more than 1 week or is accompanied by a fever, contact your health care provider. A persistent cough could be a sign of a serious condition. Carbetapentane/Guaifenesin Sustained-Release Capsules are not recommended for use in CHILDREN younger than 6 years of age. Safety and effectiveness in this age group have not been confirmed. PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Carbetapentane/Guaifenesin Sustained-Release Capsules during pregnancy. It is unknown if Carbetapentane/Guaifenesin Sustained-Release Capsules are excreted in breast milk. If you are or will be breast-feeding while you are using Carbetapentane/Guaifenesin Sustained-Release Capsules, check with your doctor or pharmacist to discuss the risks to your baby. Possible side effects of Carbetapentane/Guaifenesin Sustained-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Drowsiness; dry mouth, nose, or throat; upset stomach.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Carbetapentane/Guaifenesin side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include restlessness; seizures; severe agitation.

Proper storage of Carbetapentane/Guaifenesin Sustained-Release Capsules:

Store Carbetapentane/Guaifenesin Sustained-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Carbetapentane/Guaifenesin Sustained-Release Capsules out of the reach of children and away from pets.

General information: If you have any questions about Carbetapentane/Guaifenesin Sustained-Release Capsules, please talk with your doctor, pharmacist, or other health care provider. Carbetapentane/Guaifenesin Sustained-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people. If your symptoms do not improve or if they become worse, check with your doctor. Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Carbetapentane/Guaifenesin Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012 Database Edition 12.1.1.002 Copyright © 2012 Wolters Kluwer Health, Inc. More Carbetapentane/Guaifenesin resources Carbetapentane/Guaifenesin Side Effects (in more detail) Carbetapentane/Guaifenesin Use in Pregnancy & Breastfeeding Carbetapentane/Guaifenesin Drug Interactions Carbetapentane/Guaifenesin Support Group 0 Reviews for Carbetapentane/Guaifenesin - Add your own review/rating Compare Carbetapentane/Guaifenesin with other medications Cough

Read More:

Aortic Stenosis Medications

Definition of Aortic Stenosis: The aorta is the large artery that originates in the left ventricle (lower chamber) of the heart. Aortic stenosis is the narrowing or obstruction of the heart??s aortic valve, which prevents it from opening properly and blocks the flow of blood from the left ventricle to the aorta.

Drugs associated with Aortic Stenosis

The following drugs and medications are in some way related to, or used in the treatment of Aortic Stenosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Aortic Stenosis

Micromedex Care Notes:

Aortic Stenosis

Medical Encyclopedia:

Aortic insufficiency Aortic stenosis Congenital heart disease Mitral stenosis
Drug List: Inderal Inderal-La-Sustained-Release-Capsules

Read More:

Typhoid Vaccine Delayed-Release Capsules

Pronunciation: TIE-foyd
Generic Name: Typhoid Vaccine Live
Brand Name: Vivotif Berna Vaccine
Typhoid Vaccine Delayed-Release Capsules are used for:

Preventing typhoid fever in persons 6 years old and older who are at increased risk because they are traveling to an area where this infection is more common, have been in contact with infected individuals, or work in an environment that increases their risk (eg, lab work).

Typhoid Vaccine Delayed-Release Capsules are a vaccine. It works by stimulating the body to produce antibodies against typhoid fever.

Do NOT use Typhoid Vaccine Delayed-Release Capsules if: you are allergic to any ingredient in Typhoid Vaccine Delayed-Release Capsules you have a current infection, cancer, fever, persistent vomiting or diarrhea, other stomach illness, or HIV or another condition that weakens the immune system you are taking a sulfonamide (eg, sulfamethoxazole), another antibiotic (eg, penicillin), or a medicine that weakens the immune system (eg, cyclosporine, certain cancer medicines)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Typhoid Vaccine Delayed-Release Capsules:

Some medical conditions may interact with Typhoid Vaccine Delayed-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you have an infection or fever, chronic diarrhea, an illness affecting the stomach or intestines, undiagnosed rectal hemorrhage, or persistent vomiting, or you are receiving chemotherapy or radiation therapy

Some MEDICINES MAY INTERACT with Typhoid Vaccine Delayed-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

Antibiotics (eg, penicillin), corticosteroids (eg, prednisone), immunosuppressants (eg, certain cancer medicines, cyclosporine), or sulfonamides (eg, sulfamethoxazole) because they may decrease Typhoid Vaccine Delayed-Release Capsules's effectiveness Proguanil because it may decrease Typhoid Vaccine Delayed-Release Capsules's effectiveness. You should not take proguanil for at least 10 days after your last dose of Typhoid Vaccine Delayed-Release Capsules. Discuss any questions with your doctor

This may not be a complete list of all interactions that may occur. Ask your health care provider if Typhoid Vaccine Delayed-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Typhoid Vaccine Delayed-Release Capsules:

Use Typhoid Vaccine Delayed-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Take Typhoid Vaccine Delayed-Release Capsules with a cold or lukewarm drink 1 hour before or 2 hours after a meal. Swallow Typhoid Vaccine Delayed-Release Capsules whole. Do not break, crush, or chew before swallowing. Do not take cracked or broken capsules. Do not drink alcohol within 2 hours of taking Typhoid Vaccine Delayed-Release Capsules. Do not forget to skip a day between capsules. Take a capsule EVERY OTHER DAY as directed by your doctor. For Typhoid Vaccine Delayed-Release Capsules to be effective, you must complete all 4 doses at least 1 week before exposure to typhoid fever. If you miss a dose of Typhoid Vaccine Delayed-Release Capsules, take it as soon as possible. If you do not remember until the next day, take the dose as soon as possible and reschedule your doses from that day.

Ask your health care provider any questions you may have about how to use Typhoid Vaccine Delayed-Release Capsules.

Important safety information: Notify your doctor if you experience diarrhea, vomiting, or flu-like symptoms after taking Typhoid Vaccine Delayed-Release Capsules. This vaccine helps prevent typhoid fever, but does not provide 100% protection. It is important to also avoid infected people, food, and water. It is recommended that you receive another 4 doses of Typhoid Vaccine Delayed-Release Capsules every 5 years if you continue to be exposed to typhoid fever. Typhoid Vaccine Delayed-Release Capsules are not recommended for use in CHILDREN younger than 6 years of age; safety and effectiveness in these children have not been confirmed. PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Typhoid Vaccine Delayed-Release Capsules during pregnancy. It is not known if Typhoid Vaccine Delayed-Release Capsules are found in breast milk. If you are or will be breast-feeding while you use Typhoid Vaccine Delayed-Release Capsules, check with your doctor. Discuss any possible risks to your baby. Possible side effects of Typhoid Vaccine Delayed-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; fever; headache; muscle pain; nausea; stomach cramps or pain; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty swallowing; unusual hoarseness.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Typhoid side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Typhoid Vaccine Delayed-Release Capsules:

Store Typhoid Vaccine Delayed-Release Capsules in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C), at all times. Do not freeze. Keep Typhoid Vaccine Delayed-Release Capsules out of the reach of children and away from pets.

General information: If you have any questions about Typhoid Vaccine Delayed-Release Capsules, please talk with your doctor, pharmacist, or other health care provider. Typhoid Vaccine Delayed-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people. If your symptoms do not improve or if they become worse, check with your doctor. Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Typhoid Vaccine Delayed-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012 Database Edition 12.1.1.002 Copyright © 2012 Wolters Kluwer Health, Inc. More Typhoid Vaccine resources Typhoid Vaccine Side Effects (in more detail) Typhoid Vaccine Dosage Typhoid Vaccine Use in Pregnancy & Breastfeeding Typhoid Vaccine Drug Interactions Typhoid Vaccine Support Group 0 Reviews for Typhoid - Add your own review/rating Compare Typhoid Vaccine with other medications Typhoid Prophylaxis

Read More:

Typhoid Vaccine Delayed-Release Capsules

---

Related Posts Hematogen FA Capsules:

• Dibenyline Capsules 10mg Phenoxybenzamine Capsules 10mg
• Co danthramer capsules and Strong Co danthramer capsules
• MXL capsules 30 mg 60 mg 90 mg 120 mg 150 mg 200 mg
• Alu Cap Capsules
• Penbritin 250 mg Capsules
• Nabilone 1mg Capsules
• Zomorph capsules
• Tretinoin Capsules
• Neurontin Capsules
• Budenofalk 3mg Capsules